tirzepatide nad for Rapid and Sustainable Fat Loss Results Tirzepatide vs Semaglutide: Key Differences

It is vital to share your full medical history with your healthcare provider

You can usually just stop taking Mounjaro without needing to taper down your dose, as there are no withdrawal symptoms

Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)

These three receptors working together create what pharmacologists call a synergistic metabolic cascade